The Hanover Insurance Group, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a THG research report →
Range $203 – $260
Price Chart
About the company
The Hanover Insurance Group, Inc. (THG) is a U. S.
- CEO
- John Conner Roche
- IPO
- 1995
- Employees
- 4,900
- HQ
- Worcester, MA, US
Get TickerSpark's AI analysis on THG
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $8.36B
- P/E
- 11.54
- Fwd P/E
- 11.47
- PEG
- 0.53
- P/S
- 1.23
- P/B
- 2.48
- EV/EBITDA
- 8.76
- Div Yield
- 1.55%
- Gross Margin
- 44.41%
- Op Margin
- 14.04%
- Net Margin
- 10.97%
- ROE
- 21.03%
- ROIC
- 17.04%
Latest fiscal year · YoY change
- Revenue
- $6.60B+6.1%
- Gross Profit
- $2.87B+131.7%
- Op Income
- $843.80M
- Net Income
- $662.50M+55.5%
- EPS
- $18.51+56.2%
- OCF Growth
- +46.1%
- FCF Growth
- +47.0%
- 52W High
- $256.74
- 52W Low
- $166.54
- 50D MA
- $232.24
- 200D MA
- $205.46
- Beta
- 0.28
- RSI (14)
- 57
- Avg Volume
- 285.32K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
The Hanover delivered a strong third quarter with better-than-expected operating EPS, a 92.3% combined ratio, and continued momentum in Specialty, while management reiterated a disciplined, profitability-first stance on growth.· October 29, 2026
- Operating EPS of $5.15 was the best third quarter in company history; combined ratio was 92.3% and ex-cat combined ratio was 85.5%.
- Net written premium growth was 3.1%, with Specialty growing 6.7% excluding Hanover Specialty Industrial and Hanover Programs, Personal Lines up 1.7%, and Core Commercial up 4.6%.
- Current accident year ex-cat loss ratio improved to 55.7%; catastrophe losses were 6.8 points of the combined ratio, including 0.7 points of favorable prior-year development.
- Net investment income rose 12.7% to $131.9 million, supported by higher investable cash and reinvestment rates; fixed maturity earned yield was 4.58% versus 4.33% a year ago.
- Management said full-year combined ratio should clearly beat original guidance, though higher agent profit sharing and incentive costs will offset some of the underwriting outperformance.
The Hanover reported third-quarter operating EPS of $5.15, its best ever for a third quarter. The combined ratio was 92.3%, or 85.5% excluding catastrophes, and the current accident year loss ratio excluding catastrophes was 55.7%, improving nearly two points year over year. Catastrophe losses were 6.8 points of the combined ratio, inclusive of 0.7 points of favorable prior-year development; the expense ratio was 30.9%, and favorable ex-cat prior-year reserve development was $18.3 million. Net investment income increased 12.7% to $131.9 million. On growth, net written premium rose 3.1%, Specialty grew 6.7% excluding Hanover Specialty Industrial and Hanover Programs, Personal Lines grew 1.7%, and Core Commercial grew 4.6%. For the balance of the year, management said the full-year combined ratio should clearly beat original guidance, and fourth-quarter CAT load is 5.2%.
Jack Roche framed the quarter as evidence that Hanover’s diversified portfolio and disciplined underwriting are working. He emphasized the company’s strategy of focusing on profitability first, investing where returns are strongest, and using its mix of Specialty, preferred Personal Lines, and small-commercial Core Commercial to grow through the cycle. His tone was upbeat and confident, with repeated comments about strong momentum, strong execution, and being well-positioned for sustained profitable growth.
Jeff Farber highlighted broad-based underwriting strength, with a 92.3% combined ratio, 85.5% ex-cat combined ratio, and $5.15 operating EPS, plus a 12.7% increase in net investment income to $131.9 million. He noted $18.3 million of favorable ex-cat prior-year reserve development, a 30.9% expense ratio that was higher than plan because of better-than-expected results and associated variable compensation, and a 4.58% fixed maturity earned yield versus 4.33% a year ago. On capital, he said book value per share excluding unrealized losses rose 2.7% sequentially, Hanover repurchased about 386,000 shares for $86 million, and roughly $546 million remained under the authorization.
Analysts focused on whether Hanover’s pricing strength reflects better agency mix, how protected Specialty is from softer-market competition, and whether reserve conservatism is still increasing. Management said larger and broader agency relationships can support better performance, but emphasized that breadth, depth, and access to Specialty matter more than size alone; on Specialty, they said the small-to-middle-market focus and diversified portfolio provide some protection, and Bryan Salvatore said they still see growth into 2027-2028. Jeff Farber confirmed they are adding IBNR and that the IBNR share of total reserves is rising, while also reiterating that higher rates are helping the investment portfolio and that underwriting and investing are managed independently.
The quarter showed strong underwriting and earnings momentum, with record third-quarter operating EPS, a very strong ex-cat combined ratio, and favorable reserve development across all segments. Management sounded confident that its portfolio mix, agency relationships, and technology investments in underwriting, claims, and data exchange can support durable profitable growth.
Growth was modest in some areas, especially Personal Lines, where management pointed to competitive pressure and deliberate mix shift toward higher-value accounts that can reduce policy count growth. Core Commercial posted a combined ratio above 100% for the quarter due to catastrophe noise and seasonality, and management acknowledged expense pressure from higher profit-sharing and incentive costs when underwriting outperforms.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 99.0%
- Shares Outstanding
- 34.37M
- Float Shares
- 34.02M
of shares held by institutions
556 13F filers
Buy/sell ratio 0.46. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Congressional trading
Senate and House stock disclosures for THG, newest first.
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Vanguard Group Inc | 3.66M | ▼ 42.27K |
| Blackrock, Inc. | 3.47M | ▼ 63.05K |
| Vanguard Portfolio Management LLC | 1.94M | ▲ 20.06K |
| Price T Rowe Associates Inc | 1.83M | ▲ 447.44K |
| State Street Corp | 1.60M | ▼ 23.47K |
| Vanguard Capital Management LLC | 1.45M | ▼ 4.44K |
| Aqr Capital Management LLC | 1.34M | ▲ 327.68K |
| Invesco Ltd. | 1.19M | ▲ 741.84K |
| Dimensional Fund Advisors LP | 1.12M | ▲ 89.38K |
| Fuller & Thaler Asset Management, Inc. | 1.07M | ▼ 22.07K |
| American Century Companies Inc | 979.19K | ▼ 98.91K |
| Alliancebernstein L.P. | 909.13K | ▲ 77.58K |
Held by 555 ETFs
Biggest fund positions in THG by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Nov 11, 26 | Roche John C | other | 36,539 |
| Nov 11, 26 | Roche John C | other | 48,052 |
| Nov 11, 26 | Roche John C | other | 60,198 |
| Nov 12, 26 | Roche John C | sell | 1,100 |
| Nov 12, 26 | Roche John C | sell | 10,393 |
| Nov 12, 26 | Roche John C | sell | 2,929 |
| Nov 11, 26 | Roche John C | other | 36,539 |
| Nov 11, 26 | Roche John C | other | 48,052 |
| Nov 4, 26 | Bunting Theodore H JR | other | 450 |
| Nov 4, 26 | Lee Willard T | other | 3,006 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our THG coverage
Recent articles, reports, and earnings notes.
No research on THG yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate THG report →Hanover Insurance Rallies 34.5% in a Year: Is It Still a Good Buy?
zacks.com · Nov 20
Customer Loyalty Has Limits: Most Would Shop With a Competitor During an Unexpected Closure, Survey Finds
prnewswire.com · Nov 18
Here's Why Hanover Insurance Group (THG) is a Strong Momentum Stock
zacks.com · Nov 17
THG's Underwriting Discipline is Key to Sustaining Premium Growth
zacks.com · Nov 11
The Hanover Insurance Group (NYSE:THG) Stock: Insider Willard Lee Sells 9,946 Shares
defenseworld.net · Nov 7
Heartland Small Cap Value Plus Strategy Q3 2026 Portfolio Activity
seekingalpha.com · Nov 6
Head-To-Head Analysis: Hamilton Insurance Group (NYSE:HG) & The Hanover Insurance Group (NYSE:THG)
defenseworld.net · Nov 6
International Assets Investment Management LLC Buys 7,347 Shares of The Hanover Insurance Group, Inc. $THG
defenseworld.net · Nov 3
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.